Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

March 15-16, 2013

Las Vegas, Nevada

Scientific Agenda

Friday, March 15, 2013

7:30 am

Breakfast and registration

8:00 am

Welcome and introductions
James M. Epstein, MD

Session I: Breast Cancer Session

Moderator: James M. Epstein, MD

8:05 am

Pre-session knowledge/competence polling using ARS

8:10 am

ER/PR+ disease
G. Thomas Budd, MD

8:35 am

HER2+ disease
Christy A. Russell, MD

9:00 am

Triple negative breast cancer
Ruth M. O’Regan, MD

9:25 am

Bone directed therapy in breast cancer
Christy A. Russell, MD

9:40 am

Post-session knowledge/competence polling using ARS

9:45 am

Panel discussion: Survivorship issues in breast cancer patients

10:10 am

Coffee break

Session II: Gastrointestinal Cancers Session

Moderator: David H. Ilson, MD

10:30 am

Pre-session knowledge/competence polling using ARS

10:35 am

Personalizing therapy for CRC
Randolph J. Hecht, MD

11:00 am

Upper GI tract cancers
David H. Ilson, MD

11:25 am

New directions for the strategic targeting of GIST
Michael C. Heinrich, MD

11:45 am

Post-session knowledge/competence polling using ARS

11:50 am

Panel discussion: Challenging cases in gastrointestinal tumors

12:15 pm

Lunch

Session III: Head and Neck Cancers

Moderator: Merrill S. Keis, MD

1:15 pm

Pre-session knowledge/competence polling using ARS

1:20 pm

HPV and its impact on incidence, prognosis and therapy of SCCHN
Robert I. Haddad, MD

1:40 pm

Management of advanced SCCHN
Merrill S. Keis, MD

2:05 pm

Advances in the management of iodine-refractory thyroid cancers
Marcia S. Brose, MD, PhD

2:30 pm

Post-session knowledge/competence polling using ARS

2:35 pm

Question & answer session

2:50 pm

Coffee break

Session IV: Melanoma and other skin cancers Session

Moderator: John M. Kirkwood, MD

3:10 pm

Pre-session knowledge/competence polling using ARS

3:15 pm

Advances in molecular oncology and therapy of malignant melanoma
John M. Kirkwood, MD

3:45 pm

Emerging therapies for basal cell carcinoma
Karl D. Lewis, MD

4:00 pm

Post-session knowledge/competence polling using ARS

4:05 pm

Question & answer session

4:15 pm

Adjourn

Saturday, March 16, 2013

7:30 am

Breakfast

8:00 am

Welcome

Session V: Gynecologic Malignancies Session

Moderator: Bradley J. Monk, MD, FACOG, FACS

8:05 am

Pre-session knowledge/competence polling using ARS

8:10 am

How I manage my patients with ovarian cancer
Robert L. Coleman, MD, FACOG, FACS

8:40 am

Uncommon gynecologic malignancies
Bradley J. Monk, MD, FACOG, FACS

9:00 am

Post-session knowledge/competence polling using ARS

9:05 am

Question & answer session

Session VI: Thoracic Malignancies Session

Moderator: Corey J. Langer, MD, FACP

9:15 am

Pre-session knowledge/competence polling using ARS

9:20 am

Immunotherapy and NSCLC
Scott N. Gettinger, MD

9:40 am

Squamous Cell Carcinoma – Are we making progress?
Speaker Invited

10:00 am

Targeting signaling pathways in NSCLC
Mark A. Socinski, MD

10:20am

Coffee break

10:40 am

Maintenance therapy controversy – Switch, continue, or delay
Corey J. Langer, MD, FACP

11:00 am

Long term management of EGFR-Mutant NSCLC
Anne S. Tsao, MD

11:20 am

Post-session knowledge/competence polling using ARS

11:25 am

Panel discussion: Challenging cases in thoracic malignancies

11:50 am

Lunch

Session VII: Genitourinary Malignancies

Moderator: David M. Nanus, MD

12:50 pm

Pre-session knowledge/competence polling using ARS

12:55 pm

Update on treatment of prostate cancer
David M. Nanus, MD

1:20 pm

Managing advanced renal cell carcinoma – Balancing efficacy with quality of life
David I. Quinn, MD, PhD

1:45 pm

Post-session knowledge/competence polling using ARS

1:50 pm

Question & answer session

2:00 pm

Coffee Break

Session VIII: Supportive Care – Managing the Adverse Events Due to Molecularly Targeted Therapies Session

Moderator: James M. Epstein, MD

2:20 pm

Pre-session knowledge/competence polling using ARS

2:25 pm

Cardiovascular and pulmonary side effects
Beth Faiman, RN, MSN, APRN-BC, AOCN®

2:45 pm

Dermatologic side effects
Mario E. Lacouture, MD

3:05 pm

Managing gastrointestinal side effects
Amy L. Goodrich, BSN, MSN, CRNP-AC

3:25 pm

Post-session knowledge/competence polling using ARS

3:30 pm

Question & answer session

3:40 pm

Adjourn